Health
Sanyou Milestones | Super Trillion Common Light Chain Antibody Discovery Platform Launched
SHANGHAI, June 11, 2023 /PRNewswire/ -- On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of the nine trillion antibody discovery platforms of San...
2023-06-12 08:00
1905
ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery
NEWARK, Del., June 9, 2023 /PRNewswire/ -- ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch ofin vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to ac...
2023-06-09 19:43
3699
WATERDROP ANNOUNCES THE PROPOSED ACQUISITION OF CUNZHEN QIUSHI
BEIJING, June 9, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it has entered into definitive transaction documents in relation t...
2023-06-09 18:00
4544
WeTrade Group Inc. Announces 1-For-185 Reverse Stock Split
BEIJING, June 8, 2023 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider committed to providing technical support and digital transformation tools for enterprises across different indust...
2023-06-09 00:45
4168
E-Home Household Services Holdings Limited's subsidiary, Zhongrun Pharmaceutical Company, won the bid to represent Xi'an Liangjian Technology Company Limited, and the related performance is expected to reach RMB 10 million
FUZHOU, China, June 8, 2023 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider inChina, the Company today announced that after a fierce competition with a number of units, its holding company Zhongrun Pharmac...
2023-06-08 21:00
7896
IMBdx Expands Targeted Therapies Agreement Following Successful Evaluation of Blood-Based Genomic Profiling Assay in Prostate Cancer
SEOUL, South Korea, June 8, 2023 /PRNewswire/ -- IMBdx Inc., a premier precision cancer diagnostic company accredited by CAP, announced today its plans to broaden its collaboration with AstraZeneca, a leading global biopharmaceutical company. This expansion will advance the shift from tissue to ...
2023-06-08 20:00
2257
Sanyou's STAL helps researchers to explore the forefront of Life Sciences with high-impact literature publication
SHANGHAI, June 7, 2023 /PRNewswire/ -- Since the establishment of Super-Trillion Innovative Antibody Library (STAL), Sanyou has collaborated with or assisted scientists in publishing dozens of articles, of which 41 have a cumulative impact factor of 412.32, 14 papers have an impact factor greater...
2023-06-07 20:00
2226
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization
NEWARK, Del., June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies is no easy feat. Cell therapy products have a higher R&D...
2023-06-07 14:57
2504
InfiRay® Debuts at WIN EURASIA 2023
YANTAI, China, June 7, 2023 /PRNewswire/ -- IRay Technology Co., Ltd. (referred
to as "InfiRay
2023-06-07 14:00
2123
Nona Biosciences Appoints Steve Arkinstall, D. Phil., as Chief Scientific Advisor
CAMBRIDGE, Mass., June 6, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation and provider of integrated solutions from "Idea to IND" (I to I™), today announced the appointment of Steve Arkinstall, D.Ph...
2023-06-07 09:00
2525
ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023
SHENZHEN, China, June 6, 2023 /PRNewswire/ -- ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT (intratumoral injection) and MVR-T3011 IV (intravenous injection) in both U.S. andChina with all selected to be published (1 chosen for poster dis...
2023-06-07 08:00
2352
Fosun Pharma Participates in 2023 BIO International Convention to Demonstrate its Global Innovation Capabilities
BOSTON, June 6, 2023 /PRNewswire/ -- From June 5th to 8th (Pacific Standard Time), the 2023 BIO International Convention ("BIO 2023") will be held in Boston, Massachusetts, USA. The BIO International Convention is the world's largest gathering of the biotechnology industry along with industry-lead...
2023-06-06 22:15
3102
Fosun Pharma and IFC Partner to Improve Access to High Quality Medicines in Africa
ABIDJAN, Côte d'Ivoire, June 6, 2023 /PRNewswire/ -- To support stronger healthcare delivery and outcomes inWest Africa, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma or the Company, stock code: 600196.SH; 02196.HK) today announced a deepening partnership with IFC to help the comp...
2023-06-06 19:52
2548
Promising 2-year updated data from cadonilimab presented at 2023 ASCO highlighting promising efficacy in PD-L1-negative patients
HONG KONG, June 6, 2023 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso") released two-year updated data from a Phase Ib/II clinical study of cadonilimab – a first-in-class PD-1/CTLA-4 bispecific antibody developed by Akeso – in combination with chemotherapy as first-line therapy for advanced gastr...
2023-06-06 19:04
1898
Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025
- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest construction timeline - Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant - Key features of Plant 5 include seamless ...
2023-06-06 19:00
2156
2023 ASCO | Multi-center Data for Combination Study of GenFleet's GFH018 (TGF-β R1 inhibitor) with Anti-PD-1 Antibody Demonstrates Significant Potential to Enhance Efficacy of Immune Checkpoint Inhibitors among ICI-naïve Patients
SHANGHAI and CHICAGO, June 6, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today published the latest results from the phase Ib/II study of GFH018 (TGF-β R1 inhibitor) with toripalimab（anti-PD-1 ...
2023-06-06 19:00
1974
Acepodia Secures $100 Million Series D Financing to Advance
First-In-Class Cell Therapies with Antibody-Cell Conjugation (ACC) Platform Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipeline, including ACE1831 and ACE2016, antibody armed allogeneic gamma ...
2023-06-06 18:00
1853
Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC
SUZHOU, China and ROCKVILLE, Md., June 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that for the second consecutive year, it has release...
2023-06-06 12:20
3184
USANA Malaysia Named Top Combination Dietary Supplements Brand by Euromonitor International
USANA Malaysia awarded for fifth year in a row KUALA LUMPUR, Malaysia, June 6, 2023 /PRNewswire/ -- USANA Malaysia was recently awarded the title Top #1 Combination Dietary Supplements Brand in Malaysia by market research giant Euromonitor International—earning this elite recognition for the fift...
2023-06-06 11:00
2468
Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential
SUZHOU, China and ROCKVILLE, Md,, June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released preliminary results from a Phas...
2023-06-06 10:45
2158
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00
Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00
Most Read
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
2024-09-14 17:37
9772
Maiji Mountain Grottoes: Carved in stone, evolving in time
2024-09-14 13:23
8197
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
2024-09-16 11:50
8120
Vision China: US, China urged to find right path in ties
2024-09-14 01:10
7681
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
2024-09-18 11:30
6228